Speciality pharmaceutical group Essential Pharma has concluded the acquisition of Reminyl oral capsules from the Johnson & Johnson company, Janssen Pharmaceutica. The strategic move enhances ...

Johnson & Johnson subsidiary Janssen Pharmaceutica has licensed a range of drug candidates to BenevolentAI, a UK-based artificial intelligence company. The deal will make use of BenevolentAI’s ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

This sentiment is echoed by Martin Price, Vice President for Health Economics, Market Access and Reimbursement EMEA at the Janssen Pharmaceutical Companies of Johnson & Johnson. “The system we ...

Pfizer Supercharges Obesity Battle with Top J&J Exec ...